✦ LIBER ✦

4012 Adjuvant docetaxel and cyclofosfamide in breast cancer patients over 65 years: compliance and toxicity

✍ Scribed by C. Serrano; J. Cortés; M. Russillo; M. Bellet; P. Gómez; C. Saura; J. Pérez; A. Farriols; J. Baselga; S. Di Cosimo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Compliance and toxicity of adjuvant CMF

✍ Ermelinda De Maio; Adriano Gravina; Carmen Pacilio; Gerardo Amabile; Vincenzo La 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 288 KB

Toxicity of docetaxel plus cyclophospham

✍ Tsz-Kok YAU; Ting-Ying NG; Inda Sung SOONG; Chi-Wai CHOI; Ka-On LAM; Alice Wan-Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Quality of life and toxicity in breast c

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

The SUCCESS-Trial -toxicity analysis of

✍ W. Janni; E. Genss; B. Rack; H. Sommer; M. Rezai; A. Schneider; W. Lichtenegger; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Prospective evaluation of the drug-metab

✍ Kyu-pyo Kim; Jin-Hee Ahn; Sung-Bae Kim; Kyung Hae Jung; Dok Hyun Yoon; Jung Shin 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 306 KB

Adjuvant oral etoposide plus cisplatin (

✍ Fikri Icli; Hakan Akbulut; Handan Onur; Bulent Yalcin; Ahmet Demirkazık; Filiz Ç 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 132 KB